Horizon Blue Cross and Blue Shield of New Jersey policies, page 2

Search Horizon Blue Cross and Blue Shield of New Jersey's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

834 public policies Substrate tracks for Horizon Blue Cross and Blue Shield of New Jersey, by title.

Horizon Blue Cross and Blue Shield of New Jersey policies
PolicyDetailsCodesSource
Aqueous Shunts and Stents for GlaucomaCommercial, Medicaid—Original policy ↗
Arsenic Trioxide (Trisenox)Commercial—Original policy ↗
Arthroscopic Debridement and Lavage as Treatment for Osteoarthritis of the KneeEffective Mar 15, 2018 · Commercial, Medicaid—Original policy ↗
Arthroscopy for Treatment of Knee DerangementEffective Dec 3, 2018 · Commercial, Medicaid—Original policy ↗
Artificial Intervertebral Disc: Cervical SpineCommercial, Medicaid—Original policy ↗
Artificial Intervertebral Disc: Lumbar SpineCommercial, Medicaid—Original policy ↗
Artificial Pancreas Device SystemsCommercial, Medicaid1Original policy ↗
ASAM (SUBSTANCE USE) CRITERIACommercial, Medicaid—Original policy ↗
Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast CancerCommercial, Medicaid—Original policy ↗
Assistant at SurgeryEffective Feb 1, 2008 · Commercial, Medicaid—Original policy ↗
Assistants at SurgeryCommercial, Medicaid—Original policy ↗
Assisted Reproductive TechnologiesCommercial, Medicaid—Original policy ↗
Atezolizumab (Tecentriq)Commercial—Original policy ↗
Auditory Brainstem Implant (ABI)Effective Dec 10, 2018 · Commercial—Original policy ↗
Autografts and Allografts in the Treatment of Focal Articular Cartilage LesionsCommercial, Medicaid—Original policy ↗
Autologous Chondrocyte Implantation for Focal Articular Cartilage LesionsCommercial, Medicaid—Original policy ↗
Autologous Hematopoietic Cell Transplantation for Malignant Astrocytomas and GliomasCommercial, Medicaid—Original policy ↗
Automated Percutaneous and Percutaneous Endoscopic DiscectomyEffective May 7, 2020 · Commercial—Original policy ↗
Automated Point-of-Care Nerve Conduction TestsCommercial, Medicaid1Original policy ↗
Autonomic Nervous System TestingCommercial, Medicaid—Original policy ↗
Avelumab (Bavencio)Commercial—Original policy ↗
Axial Lumbosacral Interbody FusionCommercial—Original policy ↗
Axicabtagene Ciloleucel (Yescarta)Commercial3Original policy ↗
B-Type Natriuretic Peptide in Heart FailureCommercial, Medicaid—Original policy ↗
Balloon Dilation of the Eustachian TubeCommercial—Original policy ↗
Balloon Ostial Dilation as an Alternative to Endoscopic Sinus Surgery for Treatment of Chronic RhinosinusitisCommercial, Medicaid—Original policy ↗
Bariatric Surgery Billed with Hiatal Hernia RepairEffective Mar 2, 2014 · Commercial, Medicaid10Original policy ↗
Baroreflex Stimulation DevicesCommercial, Medicaid—Original policy ↗
BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic LeukemiaCommercial—Original policy ↗
Behavioral Health Services Rendered by Supervised PractitionersEffective Jan 1, 2023 · Commercial, Medicaid—Original policy ↗
Belatacept (Nulojix)Commercial1Original policy ↗
Belimumab (Benlysta)Commercial—Original policy ↗
Belinostat (Beleodaq)Commercial—Original policy ↗
Bendamustine Hydrochloride (Treanda®, Bendeka®, Belrapzo)Commercial—Original policy ↗
Bilateral ProceduresEffective Dec 11, 2007 · Commercial, Medicaid—Original policy ↗
Bimatoprost Implant (Durysta)Commercial—Original policy ↗
Bioengineered Skin and Soft Tissue SubstitutesCommercial, Medicaid4Original policy ↗
BiofeedbackCommercial, Medicaid—Original policy ↗
Bioimpedance Devices for Detection and Management of LymphedemaCommercial, Medicaid—Original policy ↗
Biologics CodingEffective Apr 3, 2023 · Commercial, Medicaid—Original policy ↗
BlepharoplastyCommercial, Medicaid—Original policy ↗
Blinatumomab (Blincyto)Commercial—Original policy ↗
BlueCard® Medical PoliciesCommercial—Original policy ↗
Bone Mineral Density Studies and Vertebral Fracture Assessment With DensitometryCommercial, Medicaid12Original policy ↗
Bone Morphogenetic ProteinCommercial—Original policy ↗
Bortezomib (Velcade®)Commercial—Original policy ↗
Botulinum ToxinCommercial2Original policy ↗
Brachytherapy of the Coronary ArteriesCommercial, Medicaid—Original policy ↗
BRAF Gene Mutation Testing To Select Melanoma or Glioma Patients for Targeted TherapyCommercial—Original policy ↗
Breast PumpsCommercial, Medicaid3Original policy ↗

Back to Horizon Blue Cross and Blue Shield of New Jersey

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.